Alkermes has agreed a $950 million deal to acquire Rodin Therapeutics, a US biotech developing drugs for neurodegenerative diseases. Dublin-headquartered Alkermes is paying $100 million upfront to buy ...

Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...

From persevering with a tricky Alzheimer’s program to securing a late-stage CD38-directed antibody and posting encouraging lupus data, Biogen has remained in the news recently—and that’s no accident.

July 7, 2026 • Pete Hegseth's Pentagon has been dismantling diversity initiatives and blocking the promotions of high-ranking Black officers. This week, Parker talks with The Atlantic's Clint Smith, ...

Vumerity significantly cuts multiple sclerosis relapse rates compared with Tecfidera, a real-world study found. The better results with Vumerity may be due to the newer drug's fewer gastrointestinal ...

June 16, 2026 • After nearly 10 years of planning and construction, the Obama Presidential Center is opening on the South Side of Chicago — right across the street from an under-resourced high school, ...

J is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of J shares has increased $1.31 since the market last closed. This is a 1.02% rise.

The singer made a name for herself in the film Selena in the nineties and then went on to star in big movies such as Maid In Manhattan, The Wedding Planner and Shades of Blue. As well as singing, ...

Americans have lots worth celebrating this Independence Day, even with polarized politics And it leans left The institutional backlash may prove to be too much, but she deserves credit for trying No.

Chances are, you’ve heard of the police code 10-4, which means “affirmative” or an acknowledgment of a message. But if you hear a police officer say 10-33, there’s a police emergency underway. However ...

Atlanta-based rapper J.I.D. is officially preparing for the biggest run of his career with the announcement of his 2025-2026 "God Does Like World Tours." The newly announced tour has been designed to ...